| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5656413 | HPB | 2017 | 7 Pages |
Abstract
The use of an iVAC following pancreaticoduodenectomy is associated with decreased SSI rates. This is particularly true for patients at highest risk as defined by a previously established risk scoring system in patients undergoing open pancreaticoduodenectomy.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Richard A. Burkhart, Ammar A. Javed, Sean Ronnekleiv-Kelly, Michael J. Wright, Katherine E. Poruk, Frederic Eckhauser, Martin A. Makary, John L. Cameron, Christopher L. Wolfgang, Jin He, Matthew J. Weiss,